ClinicalTrials HQ

Huntsman Cancer Institute at University of Utah

Huntsman Cancer Institute at University of Utah

Salt Lake City, Utah, United States

28 results ยท Page 1 of 2

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Loncastuximab Tesirine and Rituximab as First-line Therapy in Patients With Post-transplant Lymphoproliferative Disorder (PLUTO)post-transplant lymphoproliferative diseaseNot yet recruitingPhase 1 / Phase 22026-10-09NCT07573436
A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential ThrombocythemiaHemic and Lymphatic Diseases, Myeloproliferative Disorders, blood coagulation disease, blood platelet disease, bone marrow disorder, essential thrombocythemia, hematologic disorder, hemorrhagic disease, thrombocytosis diseaseRecruitingPhase 32026-10-08NCT07623200
Tolerability of Ropeginterferon Alfa-2b Add-on to Ongoing Ruxolitinib Therapy in MyelofibrosisHemic and Lymphatic Diseases, Myeloproliferative Disorders, bone marrow disorder, hematologic disorder, primary myelofibrosisRecruitingPhase 12026-10-01NCT07521046
Loncastuximab Tesirine and Rituximab as Bridging Therapy Before Standard-of-care CAR-T Therapy in Patients With Large B-cell Lymphoma (CORAL)Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, RecurrenceRecruitingPhase 22026-09-25NCT06788964
Mosunetuzumab in Combination With Pirtobrutinib in Patients With Relapsed or Refractory Waldenstrom Macroglobulinemia (MPOWER)Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Waldenstrom macroglobulinemia, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic diseaseNot yet recruitingPhase 22026-09-24NCT07548450
A Phase 2 Study Evaluating Bladder Preservation With Enfortumab Vedotin Plus Pembrolizumab in Patients With Muscle-Invasive Urothelial CancerMuscle-invasive Bladder Urothelial CarcinomaNot yet recruitingPhase 22026-09-16NCT07822373
Functional Precision Oncology to Predict, Prevent, and Treat Early Metastatic Recurrence of TNBCBreast Cancer RecurrentRecruitingPhase 22026-08-24NCT05464082
Nurturing Exercise Routine for Greater Improvement in Zest and Energy on EnhertuNeoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorderRecruitingPhase 22026-08-20NCT07203378
Dose-Escalation Study of Cabozantinib in Combination With Lutetium-177 (177Lu)-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate CancerMetastatic Castration-resistant Prostate CancerRecruitingPhase 12026-08-12NCT05613894
Loncastuximab Tesirine and Rituximab Following Stereotactic Radiosurgery in Patients With Central Nervous System Lymphomas (SOLAR)primary central nervous system lymphomaRecruitingPhase 12026-08-10NCT06607549
The Use of Guarana to Treat Fatigue in Patients With Neuroendocrine Tumors and Gynecologic Cancers (Guarana Fatigue)Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, female reproductive organ cancer, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumorRecruitingPhase 22026-08-07NCT07151391
A Study to Evaluate INCA035784 in Participants With Myeloproliferative NeoplasmsHemic and Lymphatic Diseases, Myeloproliferative Disorders, blood coagulation disease, blood platelet disease, bone marrow disorder, essential thrombocythemia, hematologic disorder, hemorrhagic disease, primary myelofibrosis, thrombocytosis diseaseRecruitingPhase 12026-08-06NCT07008118
Cobimetinib in Newly Diagnosed or HMA-treated CMML Patients With RAS Pathway MutationsChronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bone marrow disorder, chronic myelomonocytic leukemia, hematologic disorder, leukemia, myelodysplastic/myeloproliferative disease, myeloid leukemia, neoplasmActive, not recruitingPhase 22026-07-21NCT04409639
Pemigatinib in Patients With Relapsed or Refractory B-cell Non-Hodgkin LymphomasB-cell neoplasm, Disease Attributes, Hemic and Lymphatic Diseases, Lymphoma, B-Cell, Marginal Zone, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, mantle cell lymphoma, marginal zone lymphoma, neoplasmActive, not recruitingPhase 22026-07-09NCT06300528
XL092 in Patients With Metastatic Castration-Resistant Prostate CancerMetastatic Castration-resistant Prostate CancerRecruitingPhase 22026-06-29NCT06568562
Optimal PSA Triggered Individual Management of Androgen Sensitive Prostate CancerMetastatic Hormone-sensitive Prostate Cancer (mHSPC)RecruitingPhase 22026-06-23NCT07216248
External Beam Radiotherapy Followed by Bispecific Antibody Therapy for Relapsed/Refractory DLBCLB-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, diffuse large B-cell lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasmRecruitingPhase 12026-06-04NCT07528352
Transcranial Magnetic Stimulation for Chemotherapy-Induced Peripheral Neuropathy in Breast and Gynecologic Cancer Survivorsfemale reproductive organ cancerRecruitingNot applicable2026-06-02NCT07120100
Study of Nivolumab in Combination w Radium-223 in Men w Metastatic Castration Resistant Prostate CancerMetastatic Castration-resistant Prostate CancerActive, not recruitingPhase 12026-06-01NCT04109729
Multimodal Telerehabilitation of Rural Patients With Advanced Prostate CancerGenital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorderRecruitingNot applicable2026-04-13NCT07093177
Safety and Tolerability Study of INCB057643 in Participants With Myelofibrosis and Other Advanced Myeloid NeoplasmsDisease Attributes, Hemic and Lymphatic Diseases, Myeloproliferative Disorders, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, blood coagulation disease, blood platelet disease, bone marrow disorder, essential thrombocythemia, hematologic disorder, hemorrhagic disease, myelodysplastic syndrome, myeloproliferative neoplasm, primary myelofibrosis, thrombocytosis diseaseActive, not recruitingPhase 12026-04-01NCT04279847
Feasibility Evaluation of the Muse Magnetic Resonance Guided Focused Ultrasound SystemNeoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorderRecruitingEarly phase 12026-03-17NCT05291507
Topical Tretinoin Prophylaxis for Anti-EGFR Induced Skin Toxicity in Patients With Solid TumorsNeoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, neoplasmRecruitingPhase 22026-02-13NCT06358677
Multimodal Telerehabilitation in Patients Undergoing CAR-T Cell ImmunotherapyHemic and Lymphatic Diseases, Inflammation, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Shock, Systemic Inflammatory Response Syndrome, cytokine release syndrome, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, plasma cell neoplasmRecruitingNot applicable2026-02-05NCT07390071
Pirtobrutinib in Combination With Rituximab in Adults With Untreated Marginal Zone Lymphoma (PIONEER-MZL)B-cell neoplasm, Hemic and Lymphatic Diseases, Lymphoma, B-Cell, Marginal Zone, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, marginal zone lymphoma, neoplasmRecruitingPhase 22025-12-04NCT06390956